20250179090. Condensed Heterocyc (Newave Pharmaceutical .)
Appearance
CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES
Abstract: the disclosure includes compounds of formula (a):
CPC Classification: C07D498/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))
Search for rejections for patent application number 20250179090